ABOS acumenpharm.com Earnings per share growth this year
Collaboration with neuro-institutes combating toxic brain proteins is stimulating financial flows, as confirmed by the EPS YoY growth dynamics for Acumen Pharmaceuticals (ABOS). The current value of the indicator reaches 23.40, reflecting asset movement. Prospects are further bolstered by the industry veterans' expertise in controlling R&D costs and the strict retention of patients within ACU193 trials via major US medical centers under FDA supervision.
Financial and market metric breakdowns for Acumen Pharmaceuticals (ABOS)
- stock value and consensus price forecast:
- market capitalization data:
- book capitalization information:
- debt and solvency information:
All Debt to Shareholders' Equity Ratio Acumen Pharmaceuticals|ABOS - Long-Term Debt to Capital|Short-Term Debt to Capital acumenpharm.com|ABOS - Company Debts|Debt to Net Assets Ratio Acumen Pharmaceuticals, Inc|ABOS - Company Long-Term Debt|Company Current Liabilities Acumen Pharmaceuticals|Quick Ratio acumenpharm.com
- net income and valuation multiples indicators:
ABOS - Net Profit|Future Profit Acumen Pharmaceuticals|ABOS - P/E Multiple|Projected Price to Earnings Ratio Acumen Pharmaceuticals, Inc|ABOS - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Acumen Pharmaceuticals, Inc|ABOS - Operating profit before deduction of amortization|Earnings per share for the last four quarters Acumen Pharmaceuticals|ABOS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months acumenpharm.com|ABOS - Earnings growth in current year|Expected earnings per share growth for next year Acumen Pharmaceuticals
Basic company analysis:Acumen Pharmaceuticals Inc. (ABOS)
The development of an innovative Alzheimer's therapy defines the long-term potential of Acumen Pharmaceuticals (ABOS). However, high clinical trial costs are creating negative operating leverage. Current annual EPS growth measures the dynamics of net income per share relative to the previous year. This ratio reveals the efficiency of capital management in the absence of commercial sales. Analysis of current annual EPS growth allows for an assessment of the resilience of the business's fundamental indicators.
Main competitors
Earnings per share growth rate in current year Biogen Inc (BIIB)|Earnings per share growth in current year Neurocrine Biosciences Inc|Earnings per share growth this year RGC (Regencell Corp)|Net earnings per share growth this year AXSM (Axsome Therapeutics)|ACAD (acadia-pharm.com) - Earnings per share increase in current year|Earnings per share growth in current year Xenon XENE|VKTX (Viking Therapeutics Inc) - Earnings per share trend in current year|Supernus Pharma - Earnings growth in current year|Earnings per share increase in current year CPRX (Catalyst Corp)|DNLI: Earnings growth in current year|harmonybiosciences.com (HRMY) - Earnings growth in current year|Earnings per share growth in current year Biohaven|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Net earnings per share growth this year Praxis Corp PRAX|Earnings growth in current year AVXL (Anavex Life Sciences)|Earnings growth in current year ceribell.com CBLL|Prothena - Earnings growth in current year|Alector, Inc. (ALEC) - Net earnings per share growth this year|ANNX: Earnings growth in current year|Earnings per share growth rate in current year Omeros (OMER)|Net earnings per share growth this year NGNE|Earnings growth in current year acimmune.com|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings growth in current year SCLX (Scilex Holding Co.)|Expected net earnings per share growth this year Tevogen Bio Inc. (TVGN)|Alpha Cognition Corp - Earnings growth in current year|Cognition Therapeutics Inc. (CGTX) - Net earnings per share growth this year|IKT: Earnings growth in current year|Cassava Sciences Inc (SAVA) - Earnings growth in current year|Earnings per share growth in current year Assertio Holdings|Earnings per share growth in current year COYA|Earnings per share growth in current year Vistagen Therapeutics (VTGN)|Expected net earnings per share growth this year ovidrx.com|Earnings growth in current year CRVO (CervoMed)|Earnings growth in current year Alterity Therapeutics Ltd. ATHE|Clene Nanomedicine - Earnings growth in current year|PEPG: Earnings per share growth in current year|Jupiter Neurosciences (JUNS) - Earnings per share growth in current year|Earnings per share growth rate in current year relmada.com (RLMD)|Earnings per share growth in current year Annovis Bio|Grace Tx (GRCE) - Expected net earnings per share growth this year|Earnings per share growth in current year Firefly Neuroscience Inc (AIFF)|anewmeds.com - Earnings per share growth this year|Earnings growth in current year NRSN (NeuroSense Therapeutics Ltd.)|revivapharma.com (RVPH) - Earnings per share growth rate in current year|MTVA: Net earnings per share growth this year|NRXS - Earnings growth in current year|heliusmedical.com (HSDT) - Earnings per share growth in current year|Passage Bio - Earnings per share increase in current year|Earnings per share growth in current year Neuphoria Therapeutics, Inc.|Earnings per share growth rate in current year minervaneurosciences.com NERV|Earnings growth in current year ATHA|Earnings growth in current year Addex Therapeutics Ltd. (ADXN)|Earnings growth in current year ALZN (Alzamend Neuro)|CYCN - Net earnings per share growth this year|PTIX: Net earnings per share growth this year|KTTA - Earnings growth in current year|cortigent.com (CRGT) - Earnings per share growth in current year|Net earnings per share growth this year Avenue Therapeutics Inc.|BCLI (Brainstorm Cell Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Cara Therapeutics Inc CARA|Earnings per share growth in current year Chromocell Therapeutics (CHRO)|eliemtx.com - Earnings per share growth this year|Intra-Cellular Therapies, Inc. - Net earnings per share growth this year|Earnings per share increase in current year LBPH|MRNS - Earnings per share growth in current year|Earnings per share trend in current year NKGN|NRBO: Earnings growth in current year|sagerx.com - Earnings per share increase in current year|SNPX (Synaptogenix) - Earnings growth in current year|Earnings growth in current year Trevena Inc.|Earnings per share growth in current year Vigil Neuroscience (VIGL)|WENA (anewmeds.com) - Earnings per share increase in current year|Earnings per share growth in current year Cerevel Therapeutics CERE
